Valuation: Novartis AG

Market Cap 296B 256B 239B 220B 413B 28,212B 420B 2,809B 1,103B 14,141B 1,113B 1,089B 46,748B P/E 2026 *
22.1x
P/E 2027 * 18.9x
Enterprise Value 330B 285B 266B 244B 459B 31,363B 467B 3,123B 1,226B 15,720B 1,238B 1,210B 51,970B EV / Sales 2026 *
5.72x
EV / Sales 2027 * 5.3x
Free-Float
91.66%
Yield 2026 *
2.8%
Yield 2027 * 2.92%
1 day+0.64%
1 week-0.49%
Current month-0.49%
1 month-0.65%
3 months+11.19%
6 months+5.02%
Current year+14.95%
1 week 124
Extreme 124
127.38
1 month 121.06
Extreme 121.06
131.5
Current year 107.68
Extreme 107.68
131.5
1 year 95.59
Extreme 95.59
131.5
3 years 81.1
Extreme 81.1
131.5
5 years 72.84
Extreme 72.84
131.5
10 years 65.09
Extreme 65.09
131.5
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Compliance Officer 58 14/04/2025
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
2/17/26 A Sell 30,743 0.0015%
2/10/26 A Sell 7,500 0.0004%
2/9/26 A Sell 67,000 0.0032%
Change 5-day change 1-year change 3-year change Capi.($)
+0.64%-0.49%+35.39%+40.21% 296B
-0.52%+3.21%+85.02%+161.12% 1,057B
+0.88%+1.13%+51.13%+49.76% 625B
+0.89%-1.95%+23.73%+63.67% 435B
+0.71%+3.87%+47.45%+38.68% 363B
+0.39%-5.83%+8.64%+9.28% 249B
+1.51%+6.69%+44.34%+62.47% 222B
+3.92%-0.46%-1.21%-44.09% 209B
+1.80%+2.30%+20.79%+65.13% 165B
+2.14%+7.00%+10.44%-25.00% 153B
Average +1.09%+1.30%+32.57%+42.12% 377.33B
Weighted average by Cap. +1.04%+1.38%+46.80%+71.28%

Financials

2026 *2027 *
Net sales 57.58B 49.81B 46.52B 42.67B 80.26B 5,480B 81.53B 546B 214B 2,747B 216B 212B 9,081B 61.12B 52.87B 49.37B 45.29B 85.19B 5,817B 86.54B 579B 227B 2,916B 230B 225B 9,639B
Net income 13.78B 11.92B 11.13B 10.21B 19.21B 1,312B 19.51B 131B 51.26B 657B 51.75B 50.62B 2,173B 15.36B 13.28B 12.41B 11.38B 21.4B 1,462B 21.74B 146B 57.13B 733B 57.67B 56.41B 2,422B
Net Debt 33.11B 28.64B 26.75B 24.54B 46.15B 3,152B 46.89B 314B 123B 1,580B 124B 122B 5,222B 27.82B 24.06B 22.47B 20.61B 38.77B 2,647B 39.39B 264B 103B 1,327B 104B 102B 4,387B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
07/08/26 CHF 125.98 +0.64% 1,873,459
06/08/26 CHF 125.18 +0.58% 1,943,271
05/08/26 CHF 124.46 -0.11% 1,877,929
04/08/26 CHF 124.60 +0.08% 2,417,668
03/08/26 CHF 124.50 -1.66% 2,482,307
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
155.96USD
Average target price
154.05USD
Spread / Average Target
-1.22%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock